Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
CSTL

Market Cap: $987.67M

CI

Castle Biosciences, Inc.

CSTL

NASDAQ (NASDAQ Global Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin77.26%

EBITDA Margin-0.91%

EBIT Margin-5.27%

Pre-tax Margin-5.37%

Net Profit Margin-5.43%

Earnings Yield-1.98%

Valuation Multiples

Price / Book2.09

Price / Sales2.76

Price / Earnings-49.02

PEG0.49

Forward PEG2.20

EV / Sales2.69

EV / EBITDA-297.34

EV / Operating Cash Flow22.57

EV / Free Cash Flow-1967.69

Price / Free Cash Flow-2019.77

Price / Operating Cash Flow23.05

Cash Flow & Capital

Free Cash Flow / Share-$0.02

Operating Cash Flow / Share$1.4

Free Cash Flow Yield-0.05%

Capex / Revenue12.07%

Capex / Operating Cash Flow1.01%

Capex / Depreciation2.77

Stock Compensation / Revenue12.56%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio6.04

Quick Ratio5.85

Cash Ratio1.10

Debt / Assets0.07

Debt / Capital0.07

Debt / Equity0.08

Long-Term Debt / Capital0.02

Debt / Market Cap1.02%

Net Debt / EBITDA7.87

Solvency Ratio-0.04

Financial Leverage1.19

Efficiency & Working Capital

Asset Turnover0.64

Fixed Asset Turnover3.01

Inventory Turnover7.68

Receivables Turnover7.39

Payables Turnover8.40

Days Sales Outstanding49.39

Days Inventory Outstanding47.53

Days Payables Outstanding43.43

Operating Cycle96.91

Cash Conversion Cycle53.48

Working Capital Turnover1.27

Returns & Quality

Return on Equity-4.15%

Return on Assets-3.46%

Return on Invested Capital-6.31%

ROCE-6.36%

Return on Tangible Assets-4.17%

Operating Return on Assets-5.79%

Income Quality-2.20

Tax Burden1.01

Interest Burden1.02

Balance Sheet & Intrinsic Metrics

Enterprise Value$962.2M

Invested Capital$498.57M

Working Capital$284.59M

Tangible Asset Value$374.93M

Net Current Asset Value$249.95M

Graham Net-Net$7.15

Book Value / Share$15.46

Tangible Book Value / Share$12.33

Cash / Share$8.78

Financial Health Scores

Piotroski Score3

Altman Z-Score7.03

Revenue$357.28M

EBIT$-18.83M

Market Cap$987.36M

Working Capital$284.59M

Retained Earnings$-240.87M

Total Assets$561.18M

Total Liabilities$91.15M